Literature DB >> 1310443

Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs.

G J Gross1, J A Auchampach.   

Abstract

Single or multiple brief periods of ischemia (preconditioning) have been shown to protect the myocardium from infarction after a subsequent more prolonged ischemic insult. To test the hypothesis that preconditioning is the result of opening ATP-sensitive potassium (KATP) channels, a selective KATP channel antagonist, glibenclamide, was administered before or immediately after preconditioning in barbital-anesthetized open-chest dogs subjected to 60 minutes of left circumflex coronary artery (LCX) occlusion followed by 5 hours of reperfusion. Preconditioning was elicited by 5 minutes of LCX occlusion followed by 10 minutes of reperfusion before the 60-minute occlusion period. Glibenclamide (0.3 mg/kg i.v.) or vehicle was given 10 minutes before the initial ischemic insult in each of four groups. In a fifth group, glibenclamide was administered immediately after preconditioning. In a final series (group 6), a selective potassium channel opener, RP 52891 (10 micrograms/kg bolus and 0.1 micrograms/mg/min i.v.) was started 10 minutes before occlusion and continued throughout reperfusion. Transmural myocardial blood flow was measured at 30 minutes of occlusion, and infarct size was determined by triphenyltetrazolium staining and expressed as a percent of the area at risk. There were no significant differences in hemodynamics, collateral blood flow, or area at risk between groups. The ratio of infarct size to area at risk in the control group (28 +/- 6%) was not different from the group pretreated with glibenclamide in the absence of preconditioning (31 +/- 6%). Preconditioning produced a marked reduction (p less than 0.002) in infarct size (28 +/- 6% to 6 +/- 2%), whereas glibenclamide administered before or immediately after preconditioning completely abolished the protective effect (28 +/- 6% and 30 +/- 8%, respectively). RP 52891 also produced a significant (p less than 0.03) reduction (28 +/- 6% to 13 +/- 3%) in infarct size. These results suggest that myocardial preconditioning in the canine heart is mediated by activation of KATP channels and that these channels may serve an endogenous myocardial protective role.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1310443     DOI: 10.1161/01.res.70.2.223

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  140 in total

Review 1.  Myocardial preconditioning: basic concepts and potential mechanisms.

Authors:  S Okubo; L Xi; N L Bernardo; K Yoshida; R C Kukreja
Journal:  Mol Cell Biochem       Date:  1999-06       Impact factor: 3.396

Review 2.  If ischemic preconditioning is the gold standard, has a platinum standard of cardioprotection arrived? Comparison with NHE inhibition.

Authors:  R J Gumina; G J Gross
Journal:  J Thromb Thrombolysis       Date:  1999-07       Impact factor: 2.300

3.  Mitochondrial ATP dependent potassium channels mediate non-ischemic preconditioning by tachycardia in dogs.

Authors:  P Macho; E Solis; G Sánchez; H Schwarze; R Domenech
Journal:  Mol Cell Biochem       Date:  2001-01       Impact factor: 3.396

Review 4.  Therapeutic potential of ischaemic preconditioning.

Authors:  R J Edwards; A T Saurin; R D Rakhit; M S Marber
Journal:  Br J Clin Pharmacol       Date:  2000-08       Impact factor: 4.335

5.  Ischemic shortening of action potential duration as a result of KATP channel opening attenuates myocardial stunning by reducing calcium influx.

Authors:  Elena C Lascano; Jorge A Negroni; Héctor F del Valle
Journal:  Mol Cell Biochem       Date:  2002-07       Impact factor: 3.396

6.  Activation of ATP-dependent potassium channels is a trigger but not a mediator of ischaemic preconditioning in pigs.

Authors:  Rainer Schulz; Petra Gres; Gerd Heusch
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

Review 7.  Is impairment of ischaemic preconditioning by sulfonylurea drugs clinically important?

Authors:  J J Meier; B Gallwitz; W E Schmidt; A Mügge; M A Nauck
Journal:  Heart       Date:  2004-01       Impact factor: 5.994

8.  SUR2A C-terminal fragments reduce KATP currents and ischaemic tolerance of rat cardiac myocytes.

Authors:  R D Rainbow; D Lodwick; D Hudman; N W Davies; R I Norman; N B Standen
Journal:  J Physiol       Date:  2004-03-12       Impact factor: 5.182

9.  An electrocardiographic sign of ischemic preconditioning.

Authors:  Loek P B Meijs; Loriano Galeotti; Esther P Pueyo; Daniel Romero; Robert B Jennings; Michael Ringborn; Stafford G Warren; Galen S Wagner; David G Strauss
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-04-28       Impact factor: 4.733

10.  The mitochondrial K-ATP channel opener, diazoxide, prevents ischemia-reperfusion injury in the rabbit spinal cord.

Authors:  Glen Roseborough; Daqing Gao; Lei Chen; Michael A Trush; Shaoyu Zhou; G Melville Williams; Chiming Wei
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.